항진균제 시장 규모, 점유율, 성장 분석 : 약제 유형별, 치료 적응증별, 유형별, 투여 경로별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type, By Therapeutic Indication, By Type, By Route of Administration, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1630595
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 항진균제 시장 규모는 2023년에 149억 달러로 평가되며, 2024년 155억 달러에서 2032년에는 212억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 4.0%로 성장할 전망입니다.
항진균제 시장은 진균 감염증증의 유병률 증가와 효과적인 치료법에 대한 수요 증가로 인해 큰 폭의 성장이 예상됩니다. 항진균제 연구에 대한 활발한 투자와 함께 신약 개발 프로세스의 상당한 진전이 시장 역동성을 강화할 것으로 예상됩니다. 미개발 및 개발도상국의 신흥 국가 시장은 의료 서비스 프로바이더에게 유리한 비즈니스 기회가 될 것입니다. 그러나 항진균제 내성 및 사용 가능한 약물의 범위가 제한적이라는 문제는 장기적인 시장 확대에 제약이 될 수 있습니다. 전반적으로 수요 증가, 기술 발전, 연구에 대한 투자의 조합은 잠재적인 장애물에도 불구하고 향후 수년간 연구 시장 전망이 밝다는 것을 암시합니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
무역 분석
고객과 구매 기준의 분석
원재료의 분석
항진균제 시장 규모 : 약제 유형별
시장 개요
전신성 아졸 및 폴리엔
국소용 아졸 및 폴리엔
전신성 에키노칸딘 및 대사 길항제
기타
항진균제 시장 규모 : 치료 적응증별
시장 개요
피부사상균증
칸디다증
아스페르길루스증
기타
항진균제 시장 규모 : 유형별
시장 개요
처방전
시판약(OTC)
항진균제 시장 규모 : 투여 경로별
시장 개요
경구
국소
비경구
항진균제 시장 규모 : 유통 채널별
시장 개요
병원 약국
소매 약국·드러그스토어
온라인 약국
항진균제 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Abbott(USA)
Bayer AG(Germany)
GSK plc(UK)
Merck & Co., Inc.(USA)
Cadila Pharmaceuticals(India)
Glenmark Pharmaceuticals(India)
SCYNEXIS, Inc.(USA)
Astellas Pharma Inc.(Japan)
Arcadia Consumer Healthcare(USA)
Novartis AG(Switzerland)
Pfizer Inc.(USA)
Leadiant Biosciences, Inc.(USA)
Sun Pharmaceutical Industries Ltd.(India)
Viatris Inc.(USA)
Sanofi(France)
Gilead Sciences, Inc.(USA)
Apotex Inc.(Canada)
Aurobindo Pharma Limited(India)
Cipla Inc.(India)
Dr. Reddy's Laboratories Ltd.(India)
결론과 권장사항
KSA
영문 목차
영문목차
Global Antifungal Agents Market size was valued at USD 14.9 billion in 2023 and is poised to grow from USD 15.5 billion in 2024 to USD 21.21 billion by 2032, growing at a CAGR of 4.0% during the forecast period (2025-2032).
The antifungal agents market is poised for substantial growth, driven by the rising prevalence of fungal infections and an increasing demand for effective treatments. Significant advancements in drug discovery and development processes are expected to enhance market dynamics, alongside robust investments in antifungal research. Emerging markets in underdeveloped and developing regions present lucrative opportunities for providers. However, challenges such as antifungal resistance and the limited spectrum of available agents could pose constraints on long-term market expansion. Overall, the combination of growing demand, technological advancements, and investment in research suggests a positive outlook for the antifungal agents market in the coming years, despite the potential hurdles that may arise.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antifungal Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Antifungal Agents Market Segmental Analysis
Global Antifungal Agents Market is segmented by Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel and region. Based on Drug Type, the market is segmented into Systemic Azoles & Polyenes, Topical Azoles & Polyenes, Systemic Echinocandins & Antimetabolics and Others. Based on Therapeutic Indication, the market is segmented into Dermatophytosis, Candidiasis, Aspergillosis and Others. Based on Type, the market is segmented into Prescription and Over the counter (OTC). Based on Route of Administration, the market is segmented into Oral, Topical and Parenteral. Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Antifungal Agents Market
The global antifungal agents market is primarily driven by the rising incidence of fungal infections, which can be attributed to the widespread antibiotic resistance and the increasing prevalence of chronic infectious diseases. As more patients succumb to fungal infections due to these factors, there is an anticipated surge in the demand for antifungal agents. This escalation highlights the critical need for effective treatments to combat these infections, further propelling the market's growth. With healthcare providers seeking reliable solutions, the antifungal agents market is poised for significant expansion in response to these pressing health challenges.
Restraints in the Global Antifungal Agents Market
The global antifungal agents market faces significant limitations due to the rising phenomenon of antifungal resistance. As fungal pathogens evolve and become increasingly resistant to commonly prescribed antifungal treatments, the effectiveness of these agents diminishes, leading to a concerning epidemic of resistance. This situation poses a serious threat to the market's growth potential, as many antifungal medications may become ineffective in treating infections, ultimately impacting clinical outcomes and increasing the burden on healthcare systems. If left unaddressed, this growing challenge could hinder innovation and development of new antifungal treatments, thereby stalling market expansion in the foreseeable future.
Market Trends of the Global Antifungal Agents Market
The Global Antifungal Agents market is witnessing a notable trend towards personalized medicine, with vendors increasingly partnering with biotech firms to create tailored treatments for diverse fungal infections. By leveraging advancements in personalized approaches, such as precision diagnostics and targeted therapies, antifungal agents can enhance efficacy and improve patient outcomes. This collaboration not only addresses the unique genetic and clinical profiles of patients but also offers lucrative revenue opportunities for companies willing to innovate. As awareness of personalized medicine grows, stakeholders in the antifungal sector are positioned to capitalize on this trend, driving market growth and elevating treatment standards globally.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis
Customer & Buying Criteria Analysis
Raw Material Analysis
Global Antifungal Agents Market Size by Drug Type & CAGR (2025-2032)
Market Overview
Systemic Azoles & Polyenes
Topical Azoles & Polyenes
Systemic Echinocandins & Antimetabolics
Others
Global Antifungal Agents Market Size by Therapeutic Indication & CAGR (2025-2032)
Market Overview
Dermatophytosis
Candidiasis
Aspergillosis
Others
Global Antifungal Agents Market Size by Type & CAGR (2025-2032)
Market Overview
Prescription
Over the counter (OTC)
Global Antifungal Agents Market Size by Route of Administration & CAGR (2025-2032)
Market Overview
Oral
Topical
Parenteral
Global Antifungal Agents Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospitals Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
Global Antifungal Agents Market Size & CAGR (2025-2032)
North America (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
US
Canada
Europe (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Drug Type, Therapeutic Indication, Type, Route of Administration, Distribution Channel)
